Neuroscience
Quantum BioPharma Advances Multiple Sclerosis Drug Candidate Through Critical Toxicity Studies
Quantum BioPharma has completed key 90-day toxicity studies for its multiple sclerosis drug candidate Lucid-21-302, positioning the company to file an Investigational New Drug application with the FDA and potentially develop a first-in-class MS therapy.
Research Uncovers Early Development Patterns of Pediatric Brain Tumors
A new study explores the complex origins of medulloblastoma in specialized nerve cells, potentially offering insights for future treatment strategies in pediatric brain cancer.
Clene Inc. to Present at D. Boral Capital Global Conference in New York
Clene Inc., a late clinical-stage biopharmaceutical company developing neurological disease treatments, will participate in the D. Boral Capital Inaugural Global Conference, offering investors an opportunity to learn about its innovative research and potential therapeutics.
Dr. Nupur Ghoshal Receives Alois Alzheimer Award for Groundbreaking Dementia Research
Dr. Nupur Ghoshal, a distinguished neurologist and researcher at Washington University School of Medicine, has been honored with the prestigious Alois Alzheimer Award for her significant contributions to understanding and advancing Alzheimer's and dementia research.
Bone Science Launches Advanced Cellular Health and Brain Enhancement Supplements
Bone Science's introduction of Prime NMN and Prime Brain supplements marks a significant advancement in personalized healthcare, offering solutions for cellular regeneration and cognitive enhancement across different age groups.